BETA DRUGS
Back to Cashflow Statement
|
BETA DRUGS Last 5 Year Net Cash Inflow / Outflow History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Net Cash Inflow / Outflow | ₹118 Cr | ₹9.47 Cr | ₹1.84 Cr | ₹6.90 Cr | ₹5.04 Cr |
What is the latest Net Cash Inflow / Outflow ratio of BETA DRUGS ?
| Year | Net Cash Inflow / Outflow |
|---|---|
| Mar2025 | ₹118 Cr |
| Mar2024 | ₹9.47 Cr |
| Mar2023 | ₹1.84 Cr |
| Mar2022 | ₹6.90 Cr |
| Mar2021 | ₹5.04 Cr |
How is Net Cash Inflow / Outflow of BETA DRUGS Trending?
| Years | Net Cash Inflow / Outflow | % Change | |
|---|---|---|---|
| Mar2025 | ₹118 Cr | 1,150.30 | |
| Mar2024 | ₹9.47 Cr | 414.62 | |
| Mar2023 | ₹1.84 Cr | -73.33 | |
| Mar2022 | ₹6.90 Cr | 36.94 | |
| Mar2021 | ₹5.04 Cr | - | |
Compare Net Cash Inflow / Outflow of peers of BETA DRUGS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| BETA DRUGS | ₹2,614.1 Cr | -8% | -3.5% | 35.4% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹450,211.0 Cr | -3% | -4.1% | 16.7% | Stock Analytics | |
| DIVIS LABORATORIES | ₹228,303.0 Cr | 0.6% | 17.5% | 41.9% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹189,233.0 Cr | 1.7% | -0.6% | 35.5% | Stock Analytics | |
| CIPLA | ₹115,672.0 Cr | -2% | -0.7% | -4.9% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹98,533.5 Cr | -1.5% | -3.5% | -2.2% | Stock Analytics | |
BETA DRUGS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| BETA DRUGS | -8% |
-3.5% |
35.4% |
| SENSEX | -1.2% |
-1.2% |
-3.3% |
You may also like the below Video Courses